The phrase “no questions letter” may sound as though the U.S. Food and Drug Administration opened an email, nodded politely, and went to lunch. The reality is considerably more scientificand much more important for the future of seafood.
On May 28, 2025, the FDA completed its premarket consultation with Wildtype Inc., a San Francisco food-technology company producing cultivated coho salmon. After evaluating the company’s cell lines, production methods, ingredients, manufacturing controls, contaminant testing, and safety assessment, the agency said it had no questions at that time about Wildtype’s conclusion that its cultured salmon cell material was as safe as comparable food produced by other methods.
The decision marked the first completed FDA safety consultation for cultivated seafood in the United States. It also moved cell-cultivated salmon from an intriguing laboratory project to something that could legally appear on restaurant plateswasabi optional.
What Did the FDA Actually Decide?
News reports frequently described the development as “FDA approval.” That shorthand communicates the practical result, but it does not precisely describe the regulatory mechanism.
Wildtype participated in the FDA’s voluntary premarket consultation process for food made with cultured animal cells. The company submitted a safety narrative in June 2022 and supplied eight amendments through April 2025. Those materials addressed the identity of the salmon cells, the substances used to grow them, manufacturing controls, potential contaminants, compositional testing, and the properties of the harvested material.
After completing its evaluation, the FDA stated that it had not found a basis for concluding that Wildtype’s described process would produce adulterated food. It therefore had no further questions about the company’s safety conclusion.
A No Questions Letter Is Not a Lifetime Hall Pass
The letter applies to the specific cell lines, inputs, controls, and production process described in Wildtype’s consultation file, known as CCC 000005. It is not blanket permission to make cultured salmon by any method imaginable.
Wildtype remains legally responsible for ensuring that every food it markets is safe, wholesome, properly labeled, and compliant with federal requirements. If the company introduces a materially different cell line, production substance, or manufacturing method, the FDA strongly recommends renewed contact with the agency.
In other words, the regulatory door opened, but nobody threw away the rulebook.
How Wildtype’s Cultivated Salmon Is Made
Cultivated salmon is real animal-derived food, not a plant-based imitation and not a genetically engineered fish swimming in a tank. It begins with genuine salmon cells and grows those cells in a controlled food-production system.
From Coho Salmon Cells to a Working Cell Bank
The cells behind Wildtype’s reviewed process originally came from skeletal muscle and connective tissue taken from a juvenile coho salmon at a Washington State hatchery. Scientists selected mesenchymal cells capable of continued growth and created cryopreserved master and working cell banks.
These banks provide a standardized, traceable source for future production. Wildtype does not need to collect tissue from a new fish for every batchan arrangement that is far more practical than keeping a salmon permanently on call.
The company verifies species identity through DNA-based methods and monitors cell characteristics, growth behavior, and genetic stability. These safeguards reduce the risk of using the wrong cell line or allowing unexpected changes to go unnoticed.
Growing and Harvesting the Cells
Production begins by thawing cells from the working bank. The cells move through a “seed train,” a series of increasingly large vessels that allows their population to expand. They are ultimately grown in suspension inside controlled tanks with nutrients such as amino acids, sugars, fats, minerals, vitamins, and salts.
Once sufficient material has been produced, the cells are separated through centrifugation. The harvested material is washed three times with a water-and-sugar solution, rapidly cooled, and stored frozen under temperature monitoring.
Wildtype then combines the salmon cell material with food ingredients that help create the appearance, flavor, fat distribution, and texture expected from a salmon product. Depending on the formulation, these ingredients can include soy protein and fats derived from algae, sunflower seeds, or other sources.
What the FDA Evaluated During the Cultured Salmon Review
The FDA’s scientific memorandum shows that the consultation went well beyond asking whether the finished product looked convincing next to a mound of sushi rice. Regulators considered hazards throughout cell isolation, banking, proliferation, harvesting, washing, cooling, and subsequent food processing.
Cell Identity and Stability
One major question was whether the cells were consistently what Wildtype said they were. The safety file included species verification, microscopic characterization, RNA analysis, genetic testing, and monitoring of growth rates. Master and working cell banks were stored and tracked separately to reduce mix-ups and cross-contamination.
Microbial and Environmental Hazards
Cell-culture systems can be vulnerable to bacteria, fungi, viruses, and other unwanted biological guests. Wildtype described aseptic procedures, sterilization, sanitation controls, environmental monitoring, supplier qualification, filtration, testing, and thermal processing designed to manage those risks.
The company also developed a seafood Hazard Analysis and Critical Control Point plan, commonly called HACCP, along with current good manufacturing practices. These systems identify likely hazards, establish controls, document results, and define corrective action when something wanders off course.
Growth Media and Residual Substances
The FDA considered the substances used to help the cells grow and calculated potential consumer exposure to relevant residues. According to the scientific review, most inputs were already common in food or naturally present in conventional salmon. Washing was intended to remove much of the remaining culture medium.
No antibiotics or antifungal substances are used during Wildtype’s reviewed proliferation and harvesting stages. The FDA also assessed less familiar inputs, including a recombinant salmon growth factor and methyl-beta-cyclodextrin, and did not identify uses that caused it to question the company’s safety conclusion.
Heavy Metals and Product Composition
Wildtype provided testing data covering toxic heavy metals, microorganisms, amino acids, fatty acids, minerals, and other compositional characteristics. Some nutrient levels differed from conventional wild coho salmon, but the detected levels remained within ranges found in commonly consumed foods.
Importantly, the FDA did not declare the cultivated material nutritionally identical to a conventional salmon fillet. The agency evaluated safety, not perfect nutrient equivalence. Because harvested cells are combined with additional ingredients, the nutritional profile of the finished product depends on its complete recipe.
Is Cultivated Salmon Safe for People With Fish Allergies?
No. People allergic to salmon or other finfish should not assume that cell cultivation removes the allergen. Cultivated salmon contains genuine salmon material and must be treated as fish from an allergy perspective.
Wildtype’s commercial formulations may also contain soy, another major food allergen. Consumers should review the ingredient statement and allergen disclosure for the specific product being served. “Made in a tank” is a production description, not an invisibility cloak for allergens.
Why the FDA Letter Matters for the Seafood Industry
Wildtype’s completed consultation established an important regulatory precedent. Cultivated chicken and cultivated pork fat had already moved through federal review, but seafood follows a somewhat different path.
The FDA and the U.S. Department of Agriculture share responsibility for cultivated meat and poultry. FDA oversees cell collection, banking, and growth, while USDA takes jurisdiction at harvest for species covered by federal meat and poultry inspection laws. Most seafoodincluding coho salmonremains solely under FDA jurisdiction. Siluriformes fish, such as catfish, are a notable exception.
That distinction allowed Wildtype to proceed without a separate USDA inspection approval for its salmon. Nevertheless, the company must still comply with FDA facility registration, preventive-control, seafood HACCP, sanitation, labeling, and food-safety requirements.
A Possible New Source of Seafood
Supporters see cultivated seafood as an additional way to meet demand without requiring every serving to come from a captured or farm-raised animal. Controlled production could potentially reduce exposure to parasites, ocean pollutants, microplastics, and some heavy metals while avoiding bycatch and pressure on wild populations.
Those are potential advantages, not automatic outcomes. Environmental performance depends on the source of electricity, efficiency of the equipment, composition of growth media, facility scale, ingredient supply chains, and waste management. A stainless-steel tank does not receive a sustainability halo simply by existing.
Challenges Beyond FDA’s Cultured Salmon Evaluation
Scaling Production Without Scaling Costs
Producing small batches for tastings and selected restaurants is different from supplying supermarkets nationwide. Companies must lower the cost of nutrients, improve cell productivity, operate larger vessels reliably, and maintain consistent quality across many batches.
Capital is another obstacle. Cultivated seafood facilities require specialized equipment, sterile operations, trained staff, testing programs, and significant energy. Investors have become more demanding as the alternative-protein industry has moved from enthusiastic forecasts to the less glamorous business of manufacturing food at competitive prices.
Labeling and Consumer Understanding
The FDA’s use of “cultured salmon cell material” in its consultation does not establish that phrase as the legally required market name. Labeling remains a separate issue, and the agency advised companies to consult its nutrition and labeling specialists.
Terms such as “cultivated,” “cell-cultivated,” and “cell-cultured” attempt to tell consumers how the food was produced without suggesting it is plant-based or conventionally farmed. Clear descriptions will matter because shoppers deserve to know what they are buying without needing a biotechnology dictionary in the seafood aisle.
State Restrictions and Public Debate
Federal safety clearance does not eliminate political disagreement. Several states have adopted or considered restrictions on cultivated animal products, often citing consumer protection, farming interests, or uncertainty about the technology.
Supporters argue that bans limit consumer choice and discourage American food innovation before cultivated products have achieved meaningful market share. Critics want more independent research, transparent labeling, and evidence that environmental claims hold up at commercial scale. Both sides are likely to remain vocal; food debates rarely arrive with a mute button.
Practical Experiences and Lessons From Cultivated Salmon
For diners, the first encounter with cultivated salmon may be surprisingly ordinary. Instead of a glowing laboratory cube arriving under dramatic blue lighting, restaurant guests receive a carefully composed dish. Wildtype’s early commercial debut at Kann in Portland, Oregon, paired its salmon with pickled strawberry, spiced tomato, strawberry juice, and an epis rice cracker. The plating emphasized flavor and hospitality rather than asking customers to admire the bioreactor’s résumé.
Reported tasting experiences before and after the FDA consultation generally described a recognizable salmon flavor and soft texture, particularly in raw preparations. That does not prove every consumer will find it identical to wild or farmed salmon. Taste depends on formulation, serving temperature, seasoning, fat content, cut thickness, and personal expectation. Someone arriving determined to taste “science” may notice different things from a diner who simply wants good sushi.
What Diners Should Do
Curious consumers should approach cultivated salmon as a new food format, not as a dare. Ask how the menu describes it, whether it is served raw or cooked, and which additional ingredients are used. Anyone with a fish or soy allergy should avoid the product unless a qualified medical professional provides different guidance. Cultivation does not erase the salmon proteins that can trigger allergic reactions.
It is also reasonable to ask for nutritional information. The FDA’s letter addressed the safety of the reviewed cell material and process; it did not certify that every finished product matches conventional salmon gram for gram. Protein, sodium, omega-3 fat, and other nutrients can vary with formulation.
What Chefs and Restaurants Can Learn
For chefs, cultivated seafood offers consistency and creative possibilities, but it still demands disciplined handling. Cold-chain control, sanitation, cross-contact prevention, accurate menu language, and employee training remain essential. Restaurants should ensure that front-of-house employees can explain the product in one or two clear sentences. A ten-minute lecture on mesenchymal cells is rarely the ideal prelude to appetizers.
Early restaurant launches also demonstrate the value of thoughtful presentation. Introducing unfamiliar food in a familiar culinary setting allows diners to judge aroma, flavor, and texture rather than reacting only to terminology. Pairing the salmon with recognizable ingredients can make the experience feel like dinner instead of a technology demonstration.
What Food Companies Can Learn From Wildtype’s Review
Wildtype’s regulatory experience shows that a no questions letter is earned through extensive documentation. The FDA accepted the company’s main safety submission in 2022, then reviewed eight amendments over nearly three years. Developers need traceable cell banks, validated tests, detailed input records, contamination controls, exposure calculations, manufacturing specifications, and evidence that the process consistently produces safe material.
Companies should also separate safety clearance from commercial success. Completing an FDA consultation answers an essential question, but it does not automatically solve production cost, labeling strategy, consumer trust, state law, restaurant distribution, or nutritional optimization. Regulatory progress is a milestone, not a magic wand wearing a lab coat.
The most useful experience-based lesson is to avoid extremes. Cultivated salmon is neither a guaranteed solution to every problem in the ocean nor an inexplicable substance that appeared overnight. It is food made through a new manufacturing method, supported by genuine salmon cells, conventional food ingredients, and a substantial system of safety controls. Its long-term role will depend on transparent evidence, responsible production, appealing taste, competitive pricing, and whether consumers decide it deserves space beside wild and farmed seafood.
Conclusion
The FDA’s no questions letter for Wildtype’s cultured coho salmon was a landmark for cellular agriculture and the American seafood market. The agency examined the company’s specified production process and found no basis to challenge its conclusion that the resulting cell material was as safe as comparable food made by other methods.
The decision does not make every cultivated seafood product safe by default, guarantee nutritional equivalence, or settle debates about labeling, sustainability, cost, and state restrictions. It does, however, provide a real regulatory pathway. Cultivated salmon has officially moved beyond the “maybe someday” stageand onto actual menus.
Note: Although the event is commonly called an FDA approval, the precise action was completion of a premarket consultation and issuance of a no questions letter for Wildtype’s specifically described cultured salmon cell material and production process.
